Stocks
Promomed (PRMD) EBITDA margin MSFO (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 38.0% | 44.1% | 39.7% | 38.4% | 37.7% | ||
| Changes by years, y/y, % | +6pp | -4pp | -1pp | +0.3% | ||||
Promomed. EBITDA margin, %
Promomed. EBITDA margin, changes, pp
Promomed (PRMD) EBITDA margin MSFO (quarter values) |
||||||||
| 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | LTM ? | |||
| EBITDA margin, % | ? | 44.6% | 0.0% | 55.1% | 0.0% | 51.3% | 37.7% | |
| Changes by years, y/y, % | +6pp | -5pp | -7pp | +7pp | ||||
| Changes by quarters, q/q, % | +37pp | -45pp | -55pp | |||||
